Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Wisconsin essential diabetes mellitus care guidelines.

BIBLIOGRAPHIC SOURCE(S)

  • Wisconsin Diabetes Advisory Group. Wisconsin essential diabetes mellitus care guidelines. Madison (WI): Wisconsin Diabetes Prevention and Control Program; 2004. Various p. [246 references]

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

General Recommendations/Care

  • Perform diabetes-focused visit

    Frequency

    • Type 1*: Every 3 months
    • Type 2*: Every 3-6 months

      * Consider more often if A1c >7.0% and/or complications exist

  • Review management plan, assess problems and goals

    Frequency

    • Each focused visit; revise as needed
  • Assess physical activity

    Frequency

    • Each focused visit
  • Assess nutrition/weight/body mass index (BMI)/growth

    Frequency

    • Each focused visit

Self-Management Education

  • Refer to diabetes educator, preferably a certified diabetes educator (CDE); curriculum to include the ten key areas of the national standards for diabetes self-management education

    Frequency

    • At diagnosis, then every 6-12 months, or more as needed

Medical Nutrition Therapy

  • Refer to registered dietician, preferably a certified diabetes educator; to include areas defined by the American Dietetic Association's Nutrition Practice Guidelines.

    Frequency

    • Type 1: At diagnosis; then, if age <18, every 3-6 months; if age >18, every 6-12 months.
    • Type 2: At diagnosis; then every 6-12 months or more as needed

Glycemic Control

  • Check A1c (see Algorithm 1 in original guideline document)

    Goal: <7.0% or <1% above lab norms

    Frequency

    • Type 1: Every 3 months
    • Type 2: Every 3-6 months
  • Review goals, medications, side effects, and frequency of hypoglycemia

    Frequency

    • Each focused visit
  • Assess self-blood glucose monitoring schedule

    Frequency

    • Each focused visit, 2-4 times/day, or as recommended

Cardiovascular Care

  • Check lipid profile

    Adult goals: Total Cholesterol <200 mg/dL
    Triglycerides <150 milligrams(mg)/dL
    High-density lipoprotein (HDL) >40 mg/dL (men)
    HDL >50 mg/dL (women)
    Non-HDL (Cholesterol) <130 mg/dL
    Low-density lipoprotein (LDL) <100 mg/dL (optimal goal)
    Low-density lipoprotein <70 mg/dL (for very high risk)

    Frequency

    • Children: If >2 years, after diagnosis and once glycemic control is established. Repeat annually if abnormal. Follow National Cholesterol Education Program (NCEP III) guidelines.
    • Adults: Annually. If abnormal, follow NCEP III guidelines.
  • Blood pressure

    Adult goal: <130/80 mmHg

    Pediatric goal: below 90% of ideal for age

    Frequency

    • Each focused visit
  • Assess smoking status

    Frequency

    • Each visit; if smoker, counsel to stop; refer to cessation
  • Start aspirin prophylaxis (unless contraindicated)

    Frequency

    • Age >40 with diabetes; Age <40, individualize based on risk

Kidney Care

  • Check albumin/creatinine ratio using a random urine sample, also called urine microalbumin/creatinine ratio (see Algorithm 2 in the original guideline document)

    Frequency

    • Type 1: Begin with puberty or after 5 years duration, then annually
    • Type 2: At diagnosis, then annually
  • Check serum creatinine

    Frequency

    • At diagnosis, then annually
  • Perform routine urinalysis

    Frequency

    • At diagnosis, then as indicated

Eye Care

  • Perform dilated eye exam by an ophthalmologist or optometrist

    Frequency

    • Type 1: If age >10, within 3-5 years of onset, then annually
    • Type 2: At diagnosis, then annually; two exceptions exist (see Section 7 in the original guideline document)

Foot Care

  • Inspect feet, with shoes and socks off

    Frequency

    • Each focused visit; stress need for daily self-exam
  • Perform comprehensive lower extremity exam

    Frequency

    • Annually, with monofilament

Oral Care

  • Perform oral health screening

    Frequency

    • At diagnosis, then each focused visit
  • Advise dental exam by general dentist or periodontal specialist

    Frequency

    • At diagnosis, then every 6 months (if dentate) and every 12 months (if edentate)

Emotional/Sexual Health Care

  • Assess emotional health; screen for depression

    Frequency

    • Each focused visit
  • Assess sexual health concerns

    Frequency

    • Each focused visit

Immunizations

  • Provide influenza vaccine

    Frequency

    • Annually, if age >6 months
  • Provide pneumococcal vaccine

    Frequency

    • Once; then per Advisory Committee on Immunization Practices

Preconception and Pregnancy Care

  • Provide preconception counseling/assessment

    Frequency

    • 3-4 months prior to conception*
  • Assess contraception/discuss family planning

    Frequency

    • At diagnosis and each focused visit*
  • Screen for gestational diabetes

    Frequency

    • At 24-28 weeks gestation or sooner if high risk*

      * Consider referring to provider experienced in care of diabetic women during pregnancy.

Screening for Pre-diabetes and Diabetes

  • Perform fasting plasma glucose test or oral glucose tolerance test (see Algorithm 6 in the original guideline document)

    Frequency

    • Test all people >age 45; if normal and person has no risk factors, retest in 3 years

Screening for Pre-diabetes and Diabetes

Test all people >45 years for pre-diabetes and diabetes. If screening results are normal and person has no risk factors, re-testing should occur at 3-year intervals. Screen at a younger age or more often if the person has one or more risk factors from the following list:

  1. Body mass index >25 kilograms/m2
  2. Sedentary lifestyle
  3. Prior history of pre-diabetes/glucose intolerance
  4. Race/ethnicity (e.g., African-Americans, Hispanic-Americans, Native Americans, Asian-Americans, and Pacific Islanders)
  5. Family history of diabetes in one or more first-degree relatives
  6. History of hypertension (>140/90 mmHg)
  7. History of vascular disease
  8. History of dyslipidemia: HDL <35 mg/dL and/or a triglyceride level >250 mg/dL
  9. Markers of insulin resistance: (e.g., acanthosis nigricans and/or waist circumference >40 inches in men and >35 inches in women)
  10. History of polycystic ovary syndrome (PCOS)
  11. History of gestational diabetes mellitus (GDM) in women or delivery of a baby weighing more than nine pounds at birth

Diagnosis of Pre-diabetes and Diabetes (2004 Criteria)

Fasting Plasma Glucose (FPG)

How Performed: Blood glucose is measured after at least an 8 hour fast

Normal: <100 mg/dL

Pre-diabetes (impaired fasting glucose [IFG]): 100-125 mg/dL

Diabetes Mellitus: >126 mg/dL*

Oral Glucose Tolerance Test (OGTT)

How Performed: 75-gram glucose load (drink) is ingested after at least an 8-hour fast; blood glucose is measured at 2 hours

Normal: <140 mg/dL

Pre-diabetes (impaired glucose tolerance [IGT]): 140-199 mg/dL

Diabetes Mellitus: >200 mg/dL

Random/Casual Plasma Glucose (with symptoms)

How Performed: Blood glucose is measured at any time regardless of eating

Diabetes Mellitus: >200 mg/dL (with symptoms)* #

*Test must be confirmed by repeating on a different day

# It is not appropriate to have a person eat a meal and then draw a random glucose two hours after.

CLINICAL ALGORITHM(S)

Clinical algorithms are provided in the original guideline document for:

  • Type 2 Diabetes: Glycemic Control
  • Screening and Initial Recommendations for Diabetic Kidney Disease (Microalbuminuria and Macroalbuminuria)
  • Diabetic Foot Disorders ULCER: A Clinical Practice Pathway
  • Diabetic Foot Disorders INFECTION: A Clinical Practice Pathway
  • Diabetic Foot Disorders CHARCOT FOOT: A Clinical Practice Pathway
  • Screening for Pre-diabetes and Diabetes

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on results of clinical trials, accepted science, and expert opinions.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Wisconsin Diabetes Advisory Group. Wisconsin essential diabetes mellitus care guidelines. Madison (WI): Wisconsin Diabetes Prevention and Control Program; 2004. Various p. [246 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2004 Dec

GUIDELINE DEVELOPER(S)

Wisconsin Diabetes Prevention and Control Program - State/Local Government Agency [U.S.]

SOURCE(S) OF FUNDING

Centers for Disease Control and Prevention (CDC), Division of Diabetes Translation

GUIDELINE COMMITTEE

Guidelines Work Groups and Diabetes Advisory Group

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Workgroup Members: Mary Anderson, Wisconsin Association for Perinatal Care, Preconception and Prenatal Care Committee; Ruth Ann Berkholtz, MSSW, BCD, Licensed Clinical Social Worker, Madison Psychiatric Associates; Dory Blobner, RN, MS, CDE, Diabetes Education Coordinator, Dean Clinic; Mary Bruskewitz, RN, MS, Wisconsin Nurses Association, Capitol Area and Surrounding Communities Association of Diabetes Educators (CASCADE); Jenny Camponeschi, MS, Diabetes Prevention and Control Program, Wisconsin Department of Health and Family Services; Pat Celek, RN, CDE, Aurora Health Care; Ann Conway, RN, MS, MPA, Executive Director, Wisconsin Association for Perinatal Care; Susan Davidson, MD, St. Mary's Hospital; Sarah Dillenbeck, RD, CD, CDE, UW Medical Foundation; Robert Draeger, Retired Teacher; Sherree Drezner, ACSW, LCSW, University of Wisconsin Hospital and Clinics; Krista Eastman, BA, Consultant; April Eddy, RN, CNS, CDE, Meriter Hospital, Perinatal Clinic; Ann Ebert, PharmD, Wisconsin Association for Perinatal Care, Preconception and Prenatal Care Committee; Diane Elson, MD, University of Wisconsin Hospital and Clinics; Joan Fisher, RN, CCM, MercyCare Insurance Company; Irene Golembiewski, MA, Media Solutions, University of Wisconsin Medical School; Margo Grady, MS, CGC, Wisconsin Association for Perinatal Care, Chair, Preconception and Prenatal Care Committee Meriter Hospital; Rosalyn Haase, RD/CD, CDE, MPH, BC-ADM, Wisconsin Dietetic Association; Peter G. Hanson, MD, Peter Christiansen Health Center; Dee Helgeson, RN, CDE, Reedsburg Physicians Group; Sonja Henry, MS, CGC, Wisconsin Association for Perinatal Care, Preconception and Prenatal Care Committee; Dan Hopfensperger, Immunization Program, Wisconsin Department of Health and Family Services; Sue Hugl, RN, BSN, CDE, Froedtert and Medical College Diabetes Care Center; Anthony M. Iacopino, DMD, PhD, Wisconsin Dental Association, Marquette University School of Dentistry; Jonathan B. Jaffery, MD, University of Wisconsin Medical School, Department of Medicine, Section of Nephrology; Kate Jaeger, Diabetes Program Assistant, Sixteenth Street Community Health Center; Mary Jenny, RN, BSN, Population Health Care Coordinator, WEA Trust; Audrey Johnson, RN, MSN, CDE, Aurora Health Care; Virginia Jordan, MS, RD, CDE, West Central Wisconsin Association of Diabetes Educators (WECWAADE); Pamela Kittleson, RPh, UW Medical Foundation; Kevin P. Kortsch, DPM, Wisconsin Society of Podiatric Medicine; Christy Kreul, Physicians Plus Insurance Corporation; Leah Ludlum, RN, BSN, CDE, Diabetes Prevention and Control Program, Wisconsin Department of Health and Family Services; Steven B. Magill, MD, PhD, St. Luke's Medical Center, Aurora Health Care; Glenna McWilliams, Board Certified Pedorthist, National Pedorthic Services, Inc.; Melissa Meredith, MD, University of Wisconsin Hospital and Clinics; Kristi Michalowski, MS, CPHQ, MetaStar, Inc.; Kyle Mounts, MD, Neonatologist, Newborn Care Physicians of Southeast Wisconsin; Jane Nelson Worel, RN, MS, University of Wisconsin Hospital and Clinics, Preventive Cardiology Program; Paul M. Reber, DO, Dean Medical Center; Chandra Reddy, MD, MPH, Great Lakes Inter-Tribal Council, Inc.; Thomas Repas, MD, Affinity Medical Group, Department of Endocrinology; Tim Ringhand, RN, MPH, Diabetes Prevention and Control Program, Wisconsin Department of Health and Family Services; Fredric J. Romm, MD, MPH, Medical College of Wisconsin; Elaine Rosenblatt, NP, University of Wisconsin Hospital and Clinics; David A. Scheidt, OD, Wisconsin Optometric Association; Eva Scheppa, RN, BSN, Family Health Center of Marshfield, Marshfield Clinic; Julie Schuller, MD, MPH, Medical Director, Sixteenth Street Community Health Center; Elizabeth Spencer, RD, MS, CDE, UW Health Eau Claire Family Medicine Clinic, University of Wisconsin, Department of Family Medicine; Thomas S. Stevens, MD, Wisconsin Academy of Ophthalmology; Alisa Sunness, RD, CDE, UW Medical Foundation; Julie Thiel, RPh, Pharmacy Society of Wisconsin; Gail Underbakke, MS, RD, University of Wisconsin Hospital and Clinics, Preventive Cardiology Program, University of Wisconsin Medical Foundation, Behavioral Health Consultation Services; William Weis, DPM, FACFAS, DWS, Wisconsin Society of Podiatric Medicine; Jennifer Wilen, MPH, Learning Coordinator, Wisconsin Association for Perinatal Care; Susan Williams, RN, CDE, Nurse Diabetes Educator, St. Francis Hospital; Kara Yaeger, RN, CDE, University of Wisconsin Hospital and Clinics

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available from the Wisconsin Diabetes Prevention and Control Program Web site.

Print copies: Available from the Wisconsin Diabetes Prevention and Control Program, Bureau of Community Health Promotion, PO Box 2659, Madison, WI 53701-2659.

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

  • Wisconsin diabetes strategic plan 2004-2009. Madison (WI): Wisconsin Diabetes Advisory Group. Department of Health and Family Services, Division of Public Health, Diabetes Prevention and Control Program. 2004 Oct.
  • Making a difference: essential diabetes care in Wisconsin 2005. Webcast. 2005.
  • Diabetes self-management information and record booklet and wallet card (English and Spanish).
  • Diabetes Advisory Group. Diabetes guidelines professional presentation 2005. Madison (WI): Wisconsin Diabetes Prevention and Control Program. 2005.

Electronic copies: Available from the Wisconsin Diabetes Prevention and Control Program Web site.

Additionally, the Wisconsin Diabetes Advisory Group has made available a variety of implementation tools included in the original guideline document:

  • Body mass index (BMI) tables for adults
  • Growth charts for children
  • Diabetes self-management education records
  • Diabetes patient flow sheet/chart audit tools
  • Diabetes sick day plan
  • Diabetes eye exam consultation form
  • Annual comprehensive diabetes foot exam form
  • Office poster (available in English, Spanish, and Hmong)
  • High-risk foot stickers for patient record
  • Diabetes dental referral form
  • Patient Health Questionnaire (PHQ-9)
  • Diabetes population-based indicators
  • Personal diabetes care record cards (available in English, Spanish, and Hmong)

Electronic copies: Available in the original guideline document and from the Resources section of the Wisconsin Diabetes Prevention and Control Program Web site.

PATIENT RESOURCES

The following is available:

  • Diabetes self-management information and record booklet. Madison (WI): Wisconsin Diabetes Advisory Group. Department of Health and Family Services, Division of Public Health, Diabetes Prevention and Control Program.

Electronic copies: Available from the Wisconsin Diabetes Prevention and Control Program Web site.

Print copies: Available from the Wisconsin Diabetes Prevention and Control Program, Bureau of Community Health Promotion, PO Box 2659, Madison, WI 53701-2659; phone: (608) 261-6855.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI on July 22, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo